431 related articles for article (PubMed ID: 34297962)
21. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project.
Garrett DO; Longley AT; Aiemjoy K; Yousafzai MT; Hemlock C; Yu AT; Vaidya K; Tamrakar D; Saha S; Bogoch II; Date K; Saha S; Islam MS; Sayeed KMI; Bern C; Shakoor S; Dehraj IF; Mehmood J; Sajib MSI; Islam M; Thobani RS; Hotwani A; Rahman N; Irfan S; Naga SR; Memon AM; Pradhan S; Iqbal K; Shrestha R; Rahman H; Hasan MM; Qazi SH; Kazi AM; Saddal NS; Jamal R; Hunzai MJ; Hossain T; Marks F; Carter AS; Seidman JC; Qamar FN; Saha SK; Andrews JR; Luby SP
Lancet Glob Health; 2022 Jul; 10(7):e978-e988. PubMed ID: 35714648
[TBL] [Abstract][Full Text] [Related]
22. Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq - United States, 2018-2019.
François Watkins LK; Winstead A; Appiah GD; Friedman CR; Medalla F; Hughes MJ; Birhane MG; Schneider ZD; Marcenac P; Hanna SS; Godbole G; Walblay KA; Wiggington AE; Leeper M; Meservey EH; Tagg KA; Chen JC; Abubakar A; Lami F; Asaad AM; Sabaratnam V; Ikram A; Angelo KM; Walker A; Mintz E
MMWR Morb Mortal Wkly Rep; 2020 May; 69(20):618-622. PubMed ID: 32437343
[TBL] [Abstract][Full Text] [Related]
23. Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination.
Vadrevu KM; Raju D; Rani S; Reddy S; Sarangi V; Ella R; Javvaji B; Mahantshetty NS; Battu S; Levine MM
Vaccine; 2021 Oct; 39(45):6682-6690. PubMed ID: 34625288
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
Lightowler MS; Manangazira P; Nackers F; Van Herp M; Phiri I; Kuwenyi K; Panunzi I; Garone D; Marume F; Tarupiwa A; Ferreras E; Duri C; Luquero FJ
Vaccine; 2022 Jul; 40(31):4199-4210. PubMed ID: 35690501
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children.
Patel PD; Liang Y; Meiring JE; Chasweka N; Patel P; Misiri T; Mwakiseghile F; Wachepa R; Banda HC; Shumba F; Kawalazira G; Dube Q; Nampota-Nkomba N; Nyirenda OM; Girmay T; Datta S; Jamka LP; Tracy JK; Laurens MB; Heyderman RS; Neuzil KM; Gordon MA;
Lancet; 2024 Feb; 403(10425):459-468. PubMed ID: 38281499
[TBL] [Abstract][Full Text] [Related]
26. Seroefficacy of Vi Polysaccharide-Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV).
Voysey M; Pollard AJ
Clin Infect Dis; 2018 Jun; 67(1):18-24. PubMed ID: 29351594
[TBL] [Abstract][Full Text] [Related]
27. Laboratory characterisation of Salmonella enterica serotype Typhi isolates from Zimbabwe, 2009-2017.
Mashe T; Gudza-Mugabe M; Tarupiwa A; Munemo E; Mtapuri-Zinyowera S; Smouse SL; Sooka A; Stray-Pedersen B; Smith AM; Mbanga J
BMC Infect Dis; 2019 May; 19(1):487. PubMed ID: 31151421
[TBL] [Abstract][Full Text] [Related]
28. Extensively Drug-Resistant (XDR) Typhoid: Evolution, Prevention, and Its Management.
Akram J; Khan AS; Khan HA; Gilani SA; Akram SJ; Ahmad FJ; Mehboob R
Biomed Res Int; 2020; 2020():6432580. PubMed ID: 32462008
[TBL] [Abstract][Full Text] [Related]
29. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance.
Andrews JR; Baker S; Marks F; Alsan M; Garrett D; Gellin BG; Saha SK; Qamar FN; Yousafzai MT; Bogoch II; Antillon M; Pitzer VE; Kim JH; John J; Gauld J; Mogasale V; Ryan ET; Luby SP; Lo NC
Lancet Infect Dis; 2019 Jan; 19(1):e26-e30. PubMed ID: 30170987
[TBL] [Abstract][Full Text] [Related]
30. Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data.
Liang Y; Driscoll AJ; Patel PD; Datta S; Voysey M; French N; Jamka LP; Henrion MYR; Ndeketa L; Laurens MB; Heyderman RS; Gordon MA; Neuzil KM
Lancet Glob Health; 2023 Jan; 11(1):e136-e144. PubMed ID: 36442498
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial.
Nampota-Nkomba N; Nyirenda OM; Khonde L; Mapemba V; Mbewe M; Ndaferankhande JM; Msuku H; Masesa C; Misiri T; Mwakiseghile F; Patel PD; Patel P; Johnson-Mayo I; Pasetti MF; Heyderman RS; Tracy JK; Datta S; Liang Y; Neuzil KM; Gordon MA; Laurens MB;
Lancet Glob Health; 2022 Sep; 10(9):e1326-e1335. PubMed ID: 35961356
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.
Bilcke J; Antillón M; Pieters Z; Kuylen E; Abboud L; Neuzil KM; Pollard AJ; Paltiel AD; Pitzer VE
Lancet Infect Dis; 2019 Jul; 19(7):728-739. PubMed ID: 31130329
[TBL] [Abstract][Full Text] [Related]
34.
Tanmoy AM; Westeel E; De Bruyne K; Goris J; Rajoharison A; Sajib MSI; van Belkum A; Saha SK; Komurian-Pradel F; Endtz HP
mBio; 2018 Nov; 9(6):. PubMed ID: 30425150
[TBL] [Abstract][Full Text] [Related]
35. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas.
Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085
[TBL] [Abstract][Full Text] [Related]
36. Emergence of Extensively Drug-Resistant Salmonella Typhi Infections Among Travelers to or from Pakistan - United States, 2016-2018.
Chatham-Stephens K; Medalla F; Hughes M; Appiah GD; Aubert RD; Caidi H; Angelo KM; Walker AT; Hatley N; Masani S; Nash J; Belko J; Ryan ET; Mintz E; Friedman CR
MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(1):11-13. PubMed ID: 30629573
[TBL] [Abstract][Full Text] [Related]
37. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.
Qamar FN; Yousafzai MT; Sultana S; Baig A; Shakoor S; Hirani F; Wassay A; Khushboo S; Mehmood J; Freeman A; Date K; Garrett D
J Infect Dis; 2018 Nov; 218(suppl_4):S201-S205. PubMed ID: 30060168
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.
Lin FY; Ho VA; Khiem HB; Trach DD; Bay PV; Thanh TC; Kossaczka Z; Bryla DA; Shiloach J; Robbins JB; Schneerson R; Szu SC
N Engl J Med; 2001 Apr; 344(17):1263-9. PubMed ID: 11320385
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019.
Qamar FN; Yousafzai MT; Dehraj IF; Shakoor S; Irfan S; Hotwani A; Hunzai MJ; Thobani RS; Rahman N; Mehmood J; Hemlock C; Memon AM; Andrews JR; Luby SP; Garrett DO; Longley AT; Date K; Saha SK
Clin Infect Dis; 2020 Dec; 71(Suppl 3):S276-S284. PubMed ID: 33258934
[TBL] [Abstract][Full Text] [Related]
40. Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study.
Meiring JE; Shakya M; Khanam F; Voysey M; Phillips MT; Tonks S; Thindwa D; Darton TC; Dongol S; Karkey A; Zaman K; Baker S; Dolecek C; Dunstan SJ; Dougan G; Holt KE; Heyderman RS; Qadri F; Pitzer VE; Basnyat B; Gordon MA; Clemens J; Pollard AJ;
Lancet Glob Health; 2021 Dec; 9(12):e1688-e1696. PubMed ID: 34798028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
